Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 7/20 | 0.80 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.80 |
| ▸ | CACNA1H | O95180 | 3/20 | 0.80 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.80 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.80 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.80 |
| ▸ | IDO1 | P14902 | 2/20 | 0.77 |
| ▸ | ESR1 | P03372 | 3/20 | 0.73 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.73 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.73 |
| ▸ | BCHE | P06276 | 1/20 | 0.73 |
| ▸ | ACHE | P22303 | 1/20 | 0.73 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | XBP1 | P17861 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 2/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27013439 | 1.00 | BACE1 (0.80) | BACE1ABCG2CACNA1HSLC5A1SLC5A2 | |
| Sophoraflavanone G SCHEMBL29929166 | 0.89 | BACE1 (1.00) | BACE1ABCG2CACNA1HSLC5A1SLC5A2 | |
| Sophoraflavanone G SCHEMBL17626648 | 0.89 | BACE1 (1.00) | BACE1ABCG2CACNA1HSLC5A1SLC5A2 | |
| Sophoraflavanone G SCHEMBL29929533 | 0.89 | BACE1 (1.00) | BACE1ABCG2CACNA1HSLC5A1SLC5A2 | |
| Sophoraflavanone G SCHEMBL29776828 | 0.89 | BACE1 (1.00) | BACE1ABCG2CACNA1HSLC5A1SLC5A2 | |
| Sophoraflavanone G SCHEMBL10307524 | 0.89 | BACE1 (1.00) | BACE1ABCG2CACNA1HSLC5A1SLC5A2 | |
| Sophoraflavanone G SCHEMBL15090973 | 0.89 | BACE1 (1.00) | BACE1ABCG2CACNA1HSLC5A1SLC5A2 | |
| Sophoraflavanone G SCHEMBL904617 | 0.89 | BACE1 (1.00) | BACE1ABCG2CACNA1HSLC5A1SLC5A2 | |
| Sophoraflavanone G SCHEMBL2228023 | 0.89 | BACE1 (1.00) | BACE1ABCG2CACNA1HSLC5A1SLC5A2 | |
| SCHEMBL17626616 | 0.88 | IDO1 (1.00) | BACE1ABCG2CACNA1HSLC5A1SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8377486-B2 | Cosmetic composition containing an adenium obesum extract, use thereof and method for cosmetic care including the use thereof | LVMH RECHERCHE (FR) | 2013-02-19 | — | — | US | claimed |
| US-20100272662-A1 | COSMETIC COMPOSITION CONTAINING AN ADENIUM OBESUM EXTRACT, USE THEREOF AND METHOD FOR COSMETIC CARE INCLUDING THE USE THEREOF | LVMH RECHERCHE (FR) | 2010-10-28 | — | — | US | claimed |
| WO-2008152268-A2 | COSMETIC COMPOSITION CONTAINING AN ADENIUM OBESUM EXTRACT, USE THEREOF AND METHOD FOR COSMETIC CARE INCLUDING THE USE THEREOF | LVMH RECHERCHE (FR) | 2008-12-18 | — | — | WO | claimed |
| CN-1348762-A | Application of kusheng (sophora Flavescences) flavone in preparing hypoglycemic | LUZHOU BAOGUANG PHARMACEUTICAL (CN) | 2002-05-15 | — | — | CN | claimed |
| US-20240016777-A1 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 2024-01-18 | — | — | US | disclosed |
| US-10744219-B2 | Air freshener composition and preparation method thereof | Guorun Biotechnology (Shenzhen) Co., Ltd. (CN) | 2020-08-18 | — | — | US | disclosed |
| US-20200164096-A1 | AIR FRESHENER COMPOSITION AND PREPARATION METHOD THEREOF | Guorun Biotechnology (Shenzhen) Co., Ltd. (CN) | 2020-05-28 | — | — | US | disclosed |
| EP-3388137-B1 | AIR FRESHENER COMPOSITION AND PREPARATION METHOD THEREFOR | WANG JINGNING (CN) | 2020-04-15 | — | — | EP | disclosed |
| EP-3388137-A1 | AIR FRESHENER COMPOSITION AND PREPARATION METHOD THEREFOR | Wang, Jingning (CN) | 2018-10-17 | — | — | EP | disclosed |
| US-8414933-B2 | Brassocattleya marcella koss orchid extract and use thereof as skin depigmentation agent | L V M H RECHERCHE (FR) | 2013-04-09 | — | — | US | disclosed |
| US-8377486-B2 | Cosmetic composition containing an adenium obesum extract, use thereof and method for cosmetic care including the use thereof | LVMH RECHERCHE (FR) | 2013-02-19 | — | — | US | disclosed |
| CN-102908341-A | Vitexicarpin used as pharmaceutical active ingredient with anti-angiogenesis function | UNIV TSINGHUA | 2013-02-06 | — | — | CN | disclosed |
| WO-2010066150-A9 | GENE NETWORK-BASED METHOD FOR CONFIRMING DRUG ACTION | 清华大学 (CN) | 2011-07-21 | — | — | WO | disclosed |
| CN-102030812-A | Timosaponin A-III serving as medicinal active ingredient with angiogenesis resistance | UNIV TSINGHUA | 2011-04-27 | — | — | CN | disclosed |
| CN-102028679-A | Vitexin as active ingredient of medicine with anti-angiogenesis effect | UNIV TSINGHUA | 2011-04-27 | — | — | CN | disclosed |
| US-20100272662-A1 | COSMETIC COMPOSITION CONTAINING AN ADENIUM OBESUM EXTRACT, USE THEREOF AND METHOD FOR COSMETIC CARE INCLUDING THE USE THEREOF | LVMH RECHERCHE (FR) | 2010-10-28 | — | — | US | disclosed |
| US-20090258093-A1 | Use of a brassocattleya marcella koss orchid extract as an active agent to prevent or delay the appearance of signs of cutaneous aging | L.V.M.H. RECHERCHE | 2009-10-15 | — | — | US | disclosed |
| US-20090232758-A1 | Brassocattleya marcella koss orchid extract and use thereof as skin depigmentation agent | L V M H RECHERCHE | 2009-09-17 | — | — | US | disclosed |
| WO-2008152268-A2 | COSMETIC COMPOSITION CONTAINING AN ADENIUM OBESUM EXTRACT, USE THEREOF AND METHOD FOR COSMETIC CARE INCLUDING THE USE THEREOF | LVMH RECHERCHE (FR) | 2008-12-18 | — | — | WO | disclosed |
| CN-1348762-A | Application of kusheng (sophora Flavescences) flavone in preparing hypoglycemic | LUZHOU BAOGUANG PHARMACEUTICAL (CN) | 2002-05-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016777-A1 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | THPO, SERPINB1, SERPINC1 | BACE1 3298/4885ABCG2 1601/4885CACNA1H 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.